Clinical Trials Directory

Trials / Completed

CompletedNCT02230475

Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.

Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes Using the Environmental Exposure Unit (EEU). Part 2.

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This clinical study will use the Environmental Exposure Unit (EEU) to generate allergic rhinitis symptoms in participants under controlled conditions, to collect well-characterized biological samples (urine and blood) before and after they develop these symptoms. The EEU provides the ability to control the timing, duration and levels of allergen exposure, and also other outside environmental factors, yielding ideal biologic samples for analysis with novel, cutting-edge molecular techniques. Results from the analysis of these unique allergic rhinitis samples should help determine if the technique of urine Nuclear Magnetic Resonance analysis could be a useful diagnostic tool in allergic rhinitis. IgE testing will be done on blood samples and compared to spin prick testing and symptoms of allergic rhinitis.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-09-03
Last updated
2015-04-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02230475. Inclusion in this directory is not an endorsement.

Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes. (NCT02230475) · Clinical Trials Directory